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dominal aorta. The purpose of this article is to describe
our experience in a series of 11 patients treated by in situ
allograft replacement for prosthetic graft infection occur-
ring after descending thoracic/thoracoabdominal aortic
aneurysmectomy.
PATIENTS AND METHODS
This study includes 11 consecutive patients treated for
prosthetic graft infection after descending thoracic/thora-
coabdominal aortic aneurysmectomy at the Department
of Vascular Surgery of the Pitié-Salpêtrière University
Hospital, Paris, France, from September 1992 to May
2000. All patients were treated by replacing the prosthetic
graft with an in situ arterial allograft. No other technique
was used in the management of these complications dur-
ing the study period.
Patients. There were 10 men and one woman with a
mean age of 50.8 years (range, 32-73 years). The primary
aortic disease was degenerative aneurysm in 6 patients,
chronic type B dissection in 2 patients, inflammatory
Infection is an uncommon complication after de-
scending thoracic/thoracoabdominal aortic aneurysmec-
tomy, but it has been reported since the beginning of this
type of surgery.1 Despite its high mortality surgical treat-
ment of prosthetic graft infection is mandatory because
untreated patients almost always die. Since 1988 we have
obtained good results by using in situ arterial allograft for
replacement of infected infrarenal aortic prosthetic grafts.2
Since 1992 we have used the same technique for treat-
ment of both mycotic aneurysms and prosthetic graft
infection involving the descending thoracic or thoracoab-
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Purpose: Prosthetic graft infection is an uncommon but life-threatening complication of descending thoracic/thora-
coabdominal aortic aneurysmectomy. The purpose of this study was to assess the value of in situ arterial allografts in
the management of this complication.
Methods: From 1992 to 2000 we treated 11 consecutive patients with prosthetic graft infection after descending tho-
racic/thoracoabdominal aortic aneurysmectomy by replacing the prosthetic graft with an in situ arterial allograft.
There were 10 men and one woman with a mean age of 50.8 years (range, 32-73 years). The primary aortic disease was
degenerative aneurysm in 6 patients, chronic type B dissection in 2 patients, inflammatory aneurysm in 1 patient,
Marfan’s disease in 1 patient, and Behçet’s disease in 1 patient. Replacement involved only the descending thoracic
aorta in three patients and more or less extensive segments of the thoracoabdominal aorta in eight patients. Signs of
severe infection were present in all patients, and false anastomotic aneurysms were noted in six patients. Aortoenteric
fistula occurred in three patients and aortobronchial fistula in two patients. The causative organisms were identified in
nine patients. The mean interval between the primary surgery and reoperation was 33.4 ± 27.5 months. Reoperation
was performed under emergency conditions because of hemorrhage in three patients. Cardiopulmonary bypass with
deep hypothermic circulatory arrest was used in seven patients. Allograft replacement of the aorta was associated with
reimplantation of intercostal and/or visceral arteries in all patients.
Results: One patient died intraoperatively of heart failure during emergency surgery. Two patients died of persistent
infection during the postoperative period at 19 and 58 days. Mean follow-up was 34 ± 19 months. One patient died
during the late follow-up period after surgery of the infrarenal aorta. Another patient underwent surgery for stenoses
of one branch of a bifurcated allograft and a renal bypass graft to a solitary kidney.
Conclusions: The use of in situ arterial allografts is a significant advance in the management of prosthetic graft infec-
tion after descending thoracic/thoracoabdominal aortic aneurysmectomy provided that reoperation is performed early.
(J Vasc Surg 2001;33:671-8.)
CLINICAL RESEARCH STUDIES
aneurysm in 1 patient, aneurysm without dissection in
association with Marfan’s disease in 1 patient, and
aneurysm resulting from Behçet’s disease in 1 patient. The
aneurysm involved only the descending thoracic aorta in
three patients and the thoracoabdominal aorta in eight
patients (three type II, two type III, and three type IV
according to the classification of Crawford et al3).
Primary surgery. Primary surgery had been carried
out in our department in five patients, three after preop-
erative spinal cord arteriography.4 In all patients primary
treatment consisted of interposition of a Dacron pros-
thetic graft. Direct reimplantation of spinal cord arteries
was performed in six patients and direct reimplantation of
visceral arteries was performed in five patients.
A variety of complications occurred after primary
surgery including pulmonary infection requiring pro-
longed intensive care in five patients, acute renal insuffi-
ciency in four patients (including two who transiently
required dialysis and one treated by hemofiltration), para-
plegia in two patients who only partially recovered, acute
ischemia of the lower extremity requiring surgery in one
case, and early duodeno-paraprosthetic fistula in one case.
Altogether, severe infectious complications occurred in
nine of the 11 patients. Postoperative recovery was
uneventful in only two patients.
Diagnosis of prosthetic graft infection. The mean
interval between primary surgery and clinical manifesta-
tions of prosthetic graft infection was 18.8 ± 23.4 months
(range, 8 days to 62 months). In five patients manifesta-
tions were observed within the first postoperative month
or during initial hospitalization and thus were classified as
early complications. In the other six cases manifestations
occurred between 4 and 62 months after primary treat-
ment (mean interval, 31.0 ± 22.9 months) and were clas-
sified as late complications.
All patients were critically ill, and clinical manifesta-
tions, including fever and prostration, were consistent
with severe infection. One or more blood cultures were
positive in five of the nine patients in whom blood samples
were tested. Three patients had aortoenteric fistulas, two
duodeno-paraprosthetic fistulas causing infectious mani-
festations and one aortogastric fistula after direct rupture
of a false anastomotic aneurysm through the backside of
the stomach. Two patients had aortobronchial fistulas
with repeated hemoptysis. In one of these patients massive
hemoptysis occurred during preoperative workup requir-
ing emergency selective intubation and reoperation.
Thoracic and abdominal contrast-enhanced computed
tomography (CT) scan was performed in 10 patients.
Findings were abnormal in all patients, including isolated
periprosthetic effusion in 3 patients (Fig 1), false anasto-
motic aneurysm in 5 patients, association of both in 1
patient, and frank evidence of aortoenteric fistula in 2
patients with gas bubbles between the prosthesis and duo-
denum. Aortography was performed in seven patients.
Findings demonstrated false anastomotic aneurysm in four
patients and were normal in three patients. The false
aneurysm was located on the upper anastomosis in 2
patients, lower anastomosis in 1 patient (Fig 2), and site of
reimplantation of visceral arteries in 3 patients.
In situ arterial allograft replacement. In eight
patients the interval between diagnosis of prosthetic graft
infection and in situ arterial allograft replacement was less
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Fig 1. CT scan showing periprosthetic effusion after graft
replacement of descending thoracic aortic aneurysm.
Fig 2. Aortography showing infected false aneurysm of lower
anastomosis after graft replacement of descending thoracic aortic
aneurysm.
than 1 month. During this interval repeated pleural
drainage was performed in three patients, and emergency
treatment of an aortoenteric fistula by duodenal suture with
placement of a second in situ prosthetic graft pending avail-
ability of a suitable allograft was performed in one patient.
In the remaining three patients the interval between
diagnosis of infection and allograft replacement was 2, 6,
and 11 months. The reason for this long delay was indeci-
sion on the part of attending physicians as to diagnosis
and/or management.
The same surgical approach as in primary treatment
was used in all but one patient who underwent emergency
reoperation for aortobronchial fistula resulting in massive
hemoptysis. In this patient sternolaparotomy allowed
prompt proximal control of the aorta at a safe distance
from the lesions and prevented blood from flooding the
contralateral lung when the patient was turned.
In two patients in whom the indication for primary
treatment was type III and type IV thoracoabdominal
aneurysms, simple aortic clamping was performed. In
another patient in whom the initial indication was also
type IV thoracoabdominal aneurysm, right axillofemoral
bypass grafting was performed first. In one patient who
was initially treated for type III thoracic aneurysm an 
atriofemoral bypass was used. In the remaining seven
patients we used cardiopulmonary bypass grafting (CPB)
and deep hypothermic circulatory arrest.5 This technique
was used to facilitate control of the aorta and its branches
in cases with false anastomotic aneurysm and to ensure
optimal protection of the spinal cord and visceral organs
against ischemia during aortic clamping, the duration of
which was deemed unpredictable.
A total of 22 allografts were used including 5 aortic
arches, 13 descending thoracic aortas, and 4 aortic bifur-
cations. Twelve were fresh tissue allografts preserved at
4°C,2 and 10 were cryopreserved allografts obtained from
the Tissue Bank of the Assistance Publique-Hôpitaux de
Paris. These allografts were used in various combinations.
All anastomoses were made with monofilament sutures
(polypropylene 4/0). In nine patients the infected pros-
thetic graft was completely removed. In the remaining two
patients the available allograft material was insufficient to
allow complete replacement so that only the most infected
portion of the prosthetic graft was removed.
Revascularization involved arteries supplying visceral
organs in eight patients and one or more intercostal arteries
in six patients. It was mostly performed with the Crawford’s
technique. Associated procedures included duodenal or
gastric suture in three patients, lung resection in 3 patients
(1 pneumonectomy for hemostasis and 2 lower lobectomies
for chronic pulmonary infection), 1 left nephrectomy, 1
jejunostomy to allow artificial feeding, and 1 cholecystec-
tomy for stone excision. In addition, two splenectomies,
two left nephrectomies, and one ureteral suture on a dou-
ble J catheter were necessary to repair intraoperative
injuries inflicted during the difficult dissection.
The last step in all procedures consisted of complete
debridement of infected and/or necrotic tissue, thorough
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lavage with povidone iodine, and, whenever possible,
wrapping of the allograft with viable tissue. Omentoplasty
was performed in eight patients. Drainage was by conven-
tional chest tubes and vacuum drains. No irrigation/lavage
system was used.
Procedures were usually prolonged (mean duration,
6.25 hours; range, 4.17-9.00 hours) and hemorrhagic.
Bacteriologic findings. Results of bacteriologic cul-
tures performed preoperatively (blood samples and
pleural, retroperitoneal or periprosthetic specimens) and
intraoperatively (periprosthetic effusion specimens and
prosthetic material) identified the following microorgan-
isms in nine patients: methicillin-resistant Staphylococcus
aureus in 3 patients, Streptococcus in 1 patient, Escherichia
coli in 1 patient, Klebsiella in 1 patient, a combination of
Pseudomonas aeruginosa and Serratia in 1 patient, a com-
bination of Staphylococcus and Klebsiella in 1 patient, and
a combination of methicillin-resistant S epidermidis, P
aeruginosa, and Candida albicans in 1 patient. In two
patients who had received massive, prolonged preopera-
tive antibiotic therapy no microorganisms were identified
despite intraoperative confirmation of infection based on
the presence of pus. Antimicrobial therapy was continued
postoperatively for a mean duration of 31 days (range, 8-
60 days) and was adapted according to the culture find-
ings obtained from intraoperative samples.
RESULTS
Early results. Three patients died during the periop-
erative period. One of these deaths occurred as a result of
heart failure at the end of the procedure before the patient
could be weaned from CPB. This patient was the one who
required emergency selective bronchial intubation and left
pneumonectomy to achieve hemostasis. The other two
perioperative deaths were due to persistent infection, one
from septic shock on the 19th day after surgery and the
other from rupture of the allograft on the 58th day after
surgery. In both of these patients, reoperation had been
unduly delayed and prolonged antibiotic therapy had been
administered. The patient who died of septic shock had
incomplete removal of the infected prosthetic graft. In the
patient whose allograft ruptured hemorrhage occurred in
contact with a drain placed for treatment of secondary
pyothorax, so that it is difficult to assess the respective
roles of mechanical and infectious erosion. Both were
deemed too sick for a re-redo operation.
Nonlethal postoperative complications were observed
in four patients. Pulmonary infection occurred in three
patients who were successfully treated by antibiotic ther-
apy. One patient needed a cholecystectomy for noncalcu-
lous cholecystitis. The mean duration of treatment in
intensive care unit for the 10 patients who survived reop-
eration was 24.8 ± 16.6 days (range, 4-58 days). Seven of
the eight patients who survived the perioperative period
underwent control aortography, which demonstrated
good anatomic results in all patients.
Late results. Mean follow-up was 39 ± 19 months
(range, 2-81 months). No patient was lost to follow-up.
Local recurrence of infection was not observed. One patient
died of colon necrosis after surgery of the infrarenal aorta 8
months after placement of an in situ arterial allograft in the
thoracoabdominal position. One patient underwent suc-
cessful surgery for stenosis of one iliac branch of a bifur-
cated arterial allograft 18 months after placement. He also
had a redo operation for a stenosis of an allograft to a soli-
tary kidney 44 months after placement. CT scan performed
in five patients at 16, 18, 29, 52, and 61 months demon-
strated normal morphologic features of the allograft.
DISCUSSION
Prosthetic graft infection is an uncommon complication
of surgery of the descending thoracic and thoracoabdomi-
nal aorta. Most reports in the literature have described
infectious complications after surgical repair for congenital
aortic coarctation and traumatic rupture of the aortic isth-
mus.6 Nevertheless, infectious complications after descend-
ing thoracic/thoracoabdominal aortic aneurysmectomy are
not exceptional. In a review of 1679 surgical procedures
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Table I. Treatment of prosthetic graft infection after surgical treatment of aneurysms of the descending and 
thoracoabdominal aorta: in situ revascularization
Primary Local complications
Author Primary aortic disease treatment of infection
Najafi et al,12 1980 DTAA degenerative Tube graft Aortopulmonary fistula
McKeown et al,18 1982 DTAA degenerative Tube graft Aortobronchial fistula
Kay and Kalmar,17 1985 DTAA with pseudocoarctation Tube graft Aortoesophageal fistula
Paull and Keagy,21 1990 DTAA degenerative Patch graft Aortobronchial fistula
Matley et al,19 1991 Ruptured TAAA degenerative Tube graft None
Hollier et al,16 1993 TAAA infectious Tube graft None
Pipinos and Reddy,22 1997 TAAA degenerative Tube graft Aortoesophageal fistula
Vogt et al,41 1997 Chronic type B dissection Tube graft Aortoesophageal fistula
Azakie et al,15 1998 TAAA degenerative Tube graft None
Coselli et al,14 1999 DTAA degenerative Tube graft None
TAAA degenerative Tube graft None
DTAA, Descending thoracic aortic aneurysm; TAAA, thoracoabdominal aortic aneurysm.
Table II. Treatment of prosthetic graft infection after surgical treatment of aneurysms of the descending and 
thoracoabdominal aorta: extra-anatomic revascularization
Primary Local complications
Author Primary aortic disease treatment of infection
Shumacker et al,34 1959 Infected DTAA with coarctation Tube graft Hemorrhage
Bach et al,24 1975 DTAA degenerative Exclusion-bypass grafting None
Jaumin et al,31 1978 DTAA with coarctation Primary anastomosis False aneurysm
Odagiri et al,33 1979 Post-traumatic DTAA Tube graft False aneurysm
Crawford et al,27,28 1980 DTAA degenerative Tube graft None
Marfan DTAA with mediastinal Tube graft None
rupture
Fabiani et al,29 1980 Infected DTAA with coarctation Tube graft Septic emboli
Baulieux and Dureau,26 1982 Infected DTAA with primary Resection-bypass grafting Hemorrhage
aortoesophageal fistula
Hargrove and Edmunds,32 1984 TAAA degenerative Exclusion-bypass grafting False aneurysm anastomotic
Ruptured DTAA with coarctation Tube graft Septic emboli
Myhre et al,11 1987 DTAA degenerative Tube graft Aortoesophageal fistula
Wareing et al,35 1989 Chronic type B dissection Tube graft Aortoesophageal fistula
Barnard et al,25 1995 Infected DTAA with coarctation Resection-bypass grafting Aortoesophageal paraprosthetic fistula
fistula
Hageman et al,30 1995 TAAA degenerative primary Tube graft Aortoesophageal fistula
aortoesophageal fistula
Wong et al,36 1996 Acute type B dissection Tube graft Aortoesophageal fistula
Coselli et al,14 1999 DTAA degenerative Tube graft None
DTAA, Descending thoracic aortic aneurysm; TAAA, thoracoabdominal aortic aneurysm; AFB, axillofemoral bypass grafting.
involving the thoracoabdominal aorta in 1509 patients,
Svensson et al7 reported a total of 15 prosthetic graft infec-
tions (0.9%) (2 early and 13 late) and 13 aortoesophageal
fistulas (0.8%) (3 early and 10 late), for an overall incidence
of 1.7% (28 of 1679). The same authors also reported a
series of 832 patients undergoing repair of aneurysms of the
descending thoracic aorta,8 with 14 deaths due to local
infection including 7 prosthetic graft infections (2 late and
5 early) and 7 aortoesophageal fistulas (1 early and 6 late),
for an overall incidence again of 1.7%. In a series of 534
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patients who underwent surgical repair of aneurysm of the
descending thoracic aorta, Lawrie et al9 attributed 10
deaths (1.9%) to local infection, one graft infection (only
late prosthetic graft infection was mentioned) and nine with
aortoesophageal fistula (3 early and 6 late). In our own
experience we had one infection after 191 descending thor-
acic aortic aneurysmectomies (0.5%) and four infections
after 637 thoracoabdominal aneurysmectomies (0.6%).
Several smaller series have also reported infectious compli-
cations after this type of procedure.10-13
Delay to Management
Offending organism treatment technique Outcome (follow-up)
Candida albicans 5 mo Prosthetic graft Death (3 y), aortobronchial fistula
Haemophilus parainfluenzae 36 mo Prosthetic graft Good result (3 y)
Unspecified 10 y Prosthetic graft Recurrence treated by ventral aorta, death (48 h)
H parainfluenzae 14 mo Prosthetic graft Good result (3 y)
Klebsiella 6 wk Percutaneous catheter drainage Good result (2 y)
C albicans 2 y Percutaneous aspiration Alive at 5 y, dialysis, 2 false aneurysms
Negative culture findings 14 mo Prosthetic graft Good result (18 mo)
Negative culture findings 2 mo Allograft Good result (17 mo), stenosis of allograft treated
by dilation
Unspecified 30 mo Arterial autograft Good result (9.5 y)
H influenzae 6 y Prosthetic graft Good result (follow-up?)
Staphylococcus epidermidis 1 y Prosthetic graft Death (45 days), paraplegia, aortopulmonary fistula
Delay to Management
Offending organism treatment technique Outcome (follow-up)
Staphylococcus aureus 1 y Ventral aorta Death (3 days)
Pseudomonas aeruginosa 13 y Bilateral AFB Good result (8 mo)
S aureus 3 wk Ventral aorta Good result (5 y), reoperation distal false aneurysm
P aeruginosa 6.5 mo Ventral aorta Good result (21 mo)27
Serratia aquefaciens, 5 wk Ventral aorta Death (3.5 y) from rupture of proximal aortic stump
Enterobacter agglomerans,
Peptococcus prevotic, 
Candida albicans
S epidermidis 11 wk Ventral aorta Death (3 y) from aortoesophageal fistula
S aureus 4 mo Ventral aorta Good result (10 y)
K pneumoniae, P aeruginosa 8 days Ventral aorta Good result (18 mo)
Enterococcus 4 mo Ventral aorta Good result (42 mo)
Aspergillus 6 mo Ventral aorta Good result (11 mo)
Unspecified 19 y Ventral aorta Good result (unspecified)
Multiple unspecified agents 2 wk Right AFB Death (9 days) from kidney and digestive tract ischemia
Streptococcus milleri 21 mo Ventral aorta Good result (12 mo)
E sabazakic 50 days Right AFB Death (20 days) from dissection of proximal aorta
Positive culture findings for 4 mo Ventral aorta Death (within hours) from hemorrhage
unspecified agent
Enterococcus, S aureus, Streptococcus 2 y Right AFB Death (180 days), sepsis, multiorgan failure
Prosthetic graft infection after descending thoracic/tho-
racoabdominal aortic aneurysmectomy is an extremely life-
threatening complication. In the series of Svensson et al,7
the mortality rate was 80% (12 of 15), whereas Coselli et al14
lost two of their three patients.
Few clinical studies have described results of manage-
ment of prosthetic graft infection after descending tho-
racic/thoracoabdominal aortic aneurysmectomy (Tables I
and II).11,12,14-36 Furthermore, available data are probably
biased because most reports have dealt with sporadic
patients with a majority of descending thoracic aneurysms
and insufficient follow-up to rule out late recurrence of
infection and confirm that treatment was curative. In two
chronologically separate reports Crawford et al27,28
described two patients who had successful outcomes at 10
and 11 months and later died at 3.5 and 3 years, respec-
tively, as a result of rupture of the proximal aortic stump
after ascending aorta to abdominal aorta bypass grafting
followed by graft excision.
Diagnosis of infection of an intrathoracic prosthetic
graft can be difficult. Clinical manifestations of infection
may be more or less frank. Acute complications may occur
such as gastrointestinal bleeding due to aortoesophageal
or aortoduodenal fistula, hemoptysis due to aorto-
bronchial or aortopulmonary fistula, or distal septic
embolism. CT scan is probably the most useful diagnostic
modality. It can detect periprosthetic effusion and allow
guided aspiration for bacteriologic study. Presence of air
bubbles in contact with the prosthesis is a characteristic
feature of aortointestinal fistula. Bronchial and digestive
endoscopy can be useful to locate the source of hemopty-
sis and hematemesis. Aortography is helpful to detect false
anastomotic aneurysm and visualize visceral and inter-
costal aortic branches. In patients with subacute and
chronic manifestations, indium-111 labeled white blood
cell scintigraphy18 and selective arterial catheterization
with serial cultures24 have been reported to be useful in
confirming the presence of infection. Preoperative identi-
fication of the offending microorganism is necessary to
allow adequate antimicrobial therapy.
The aims of surgical treatment are eradication of aor-
tic infection by removing the infected prosthetic graft and
revascularization of the distal aorta and its branches. One
alternative is extra-anatomic bypass grafting to achieve dis-
tal revascularization followed by removal of the infected
prosthetic graft, debridement of infected and/or necrotic
periprosthetic tissue, and suture of the aortic stumps. To
minimize surgical trauma, some authors have used unilat-
eral right axillofemoral bypass grafting to achieve distal
revascularization.30,35 However, the diameter of this
bypass graft is often insufficient to supply abdominal
organs, spinal cord, and lower extremities and relieve
hypertension in the proximal arterial system. Bach et al24
accomplished successful treatment by using bilateral
axillofemoral bypass grafting.
In theory the most appropriate extra-anatomic revas-
cularization technique is prosthetic graft bypass between
the ascending aorta (exposed through median sternotomy
or right thoracotomy) and the abdominal aorta, the so-
called ventral aorta.11,25-36 The revascularization route is
at a safe distance from the infected field so that effective
local treatment of infection without special protection can
be undertaken during clamping either immediately or later
if so required by the patient’s status. However, there are a
number of limitations to the use of this technique.
Contraindications are common (eg, when primary treat-
ment included revascularization of arteries supplying the
spinal cord or visceral organs or when massive hemorrhage
requires immediate control of the aorta). Infection of the
new prosthetic graft cannot be ruled out. As after surgery
of the infrarenal aorta, complications can develop on the
aortic stump, and false aneurysm of the aortic stump with
or without infection can result in rupture or esophageal or
airway fistula.28 Because of these limitations, the use of the
ventral aorta technique should be restricted to patients
presenting with prosthetic graft infection limited to the
descending thoracic aorta in whom clinical condition does
not require prompt exposure of the aorta (no hemor-
rhage) and a two-stage procedure is preferable.
In situ reconstruction is the only option in patients
requiring replacement of a thoracoabdominal prosthetic
graft with revascularization of spinal cord and visceral
arteries and in cases involving acute hemorrhage. All
reports of successful treatment without removal of the
infected prosthetic graft have been anecdotal or experi-
mental including repair of the anastomosis, percutaneous
catheter drainage under CT scan guidance,19 omento-
plasty, and myoplasty.20 Removal and replacement of the
infected prosthetic graft is the method of choice, but the
procedure is often difficult, prolonged, and hemorrhagic.
The two main problems are (1) proximal control of the
aorta, especially in patients presenting with rupture or
large false anastomotic aneurysms, and (2) protection
against spinal cord and visceral ischemia. To solve these
problems we have used CPB and deep hypothermic circu-
latory arrest in patients with infected prosthetic grafts that
are not predominantly infradiaphragmatic, (ie, in all
patients except those with types III and IV thoracoab-
dominal aneurysms).
Although successful replacement with a prosthetic
graft37,38 has been reported in patients with mycotic
aneurysms of the descending thoracic and thoracoabdom-
inal aorta, we think that the usefulness of this method is
limited for infected prosthetic graft replacement. As an
alternative and following on our experience in the treat-
ment of infected infrarenal aortic prosthetic grafts,2 we
have been using in situ arterial allografts in the thoracic
position for the last 9 years. At least two historical reports
have described use of allografts for treatment of local infec-
tion after surgery of the descending thoracic aorta.39,40
More recently Vogt et al41 reported on a patient with pros-
thetic graft infection after repair of a chronic type B aortic
dissection that was successfully managed with an in situ
allograft with a follow-up of 17 months.
Use of arterial allografts poses several problems. The
first concerns resistance to infection. Experimental
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data42,43 and clinical experience with both the ascending
and abdominal aortas indicate that arterial allografts are
resistant to most bacteria except necrotizing microorgan-
isms such as Pseudomonas aeruginosa. Vogt et al44 also
reported excellent resistance to infection for cryopre-
served allografts used in the treatment of both sponta-
neous and postoperative infections of the descending
thoracic aorta, although most of the offending organisms
involved in their study were of low-grade virulence.
Another possible problem raised by the use of in situ
arterial allografts is long-term stability. Although harvest-
ing and preservation techniques have advanced greatly
since the 1950s and 1960s, regular screening at least
annually by means of plain chest roentgenography,
abdominal ultrasound scanning or, preferably, thoracoab-
dominal CT scan is necessary to detect signs of potential
deterioration such as calcification, aneurysm,45 and mural
thrombosis. The incidence of these complications has
been lower than expected in our experience. We initially
envisioned in situ allograft replacement as a bridge allow-
ing treatment of infection for a few years before placement
of a second prosthetic graft. Until now we have not been
obliged to carry out the last step in this strategy for any
allograft whether at the thoracic or abdominal level.
However, follow-up is still short at the thoracic level.
Despite these problems and given the high mortality
rate after conventional management, our experience sug-
gests that the use of in situ arterial grafts is justified in the
management of infected prosthetic grafts after descending
thoracic/thoracoabdominal aortic aneurysmectomy. The
promising results in our series were achieved despite the
high-grade virulence of microbial agents causing major
infection in most of our patients. The two deaths due to per-
sistent infection were in patients who had unduly delayed
reoperation and prolonged preoperative antibiotic therapy.
Apart from another patient who died intraoperatively of car-
diac failure, all other patients survived without recurrent
infection, a result that is not obtained by conventional tech-
niques. Broader clinical experience and longer follow-up will
be needed to define the exact role of in situ allografts in the
management of infected prosthetic grafts after descending
thoracic/thoracoabdominal aortic aneurysmectomy.
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